Statistics for Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma: Phase 1 Results of a Multicenter Phase 1/2 Clinical Trial
Total visits
| views | |
|---|---|
| Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma: Phase 1 Results of a Multicenter Phase 1/2 Clinical Trial | 71 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 1 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
File Visits
| views | |
|---|---|
| nihms-1625334.pdf | 43 |
Top country views
| views | |
|---|---|
| United States | 63 |
| Canada | 1 |
| Germany | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 47 |
| Ashburn | 5 |
| Ann Arbor | 4 |
| Fairfield | 3 |
| Lake Mary | 2 |
| Baltimore | 1 |
| Calgary | 1 |
| Cambridge | 1 |
| Freudenstadt | 1 |
| Kista | 1 |